Connect with us

Solian (amisulpride)

Amisulpride (or SOLIAN®) is mainly prescribed to treat schizophrenia and dysthymia.

First Approval: 1991 (International: Asia, Europe, Australia, South Africa, Brazil)

Dosage Forms: 50 mg, 100 mg, 200 mg, 400 mg

Biological Half-life: 12 hours

Side Effects: Dizziness, headache, anxiety, insomnia, nausea, hypersalivation, hyperactivity, movement problems

Routes of Administration: Oral, IV

Pregnancy Category: C (AU)

Like Us